Quarterly report [Sections 13 or 15(d)]

Other Items (Tables)

v3.26.1
Other Items (Tables)
6 Months Ended
Mar. 31, 2026
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract]  
Schedule of Cash and Cash Equivalents
Table 10.1: Details of Cash and Cash Equivalents and Restricted Cash
March 31, 2026 September 30, 2025
(in thousands)
Cash and cash equivalents $ 157,452  $ 222,351 
Restricted cash 87,245  38,108 
Cash, cash equivalents, and restricted cash $ 244,697  $ 260,459 
Schedule of Restricted Cash and Cash Equivalents
Table 10.1: Details of Cash and Cash Equivalents and Restricted Cash
March 31, 2026 September 30, 2025
(in thousands)
Cash and cash equivalents $ 157,452  $ 222,351 
Restricted cash 87,245  38,108 
Cash, cash equivalents, and restricted cash $ 244,697  $ 260,459 
Schedule of Supplementary Cash Flow Information
Table 10.2: Supplemental Disclosures of Cash Flow Information
For the Six Months Ended
March 31, 2026 March 31, 2025
(in thousands)
Interest payments $ 41,395  $ 38,767 
Income tax payments $ 67,349  $ 70,397 
Schedule of Accounts Receivable, Net
Table 10.3: Details of Accounts Receivable, Net
March 31, 2026 September 30, 2025
(in thousands)
Billed and billable receivables $ 868,089  $ 720,495 
Unbilled receivables 255,669  187,372 
Allowance for credit losses (8,798) (9,772)
Accounts receivable, net $ 1,114,960  $ 898,095